Erenumab | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Erenumab
Health Canada Patents

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

evonik-m-2025-09-08

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Erenumab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

43 Drugs in Development

43 Drugs in Development

FINISHED DOSAGE FORMULATIONS

10 FDF Dossiers, 1 FDA Orange Book, 5 Europe, 2 Canada, 2 South Africa

10 FDF Dossiers
1 FDA Orange Book
5 Europe
2 Canada
2 South Africa

DIGITAL CONTENT

56 News #PharmaBuzz

56 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 5 Regulatory FDF Prices, 11 Annual Reports

1 US Medicaid Prescriptions
5 Regulatory FDF Prices
11 Annual Reports

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 8Gowling WLG (Canada) LLP

filter Patent Reset all filters

8 All

01 42746858

02 42984254

filter Product Reset all filters

8 All

01 8ERENUMAB

filter Dosage Reset all filters

8 All

01 8SOLUTION

filter Exp Date Reset all filters

8 All

01 42029-12-18

02 42035-08-10

Product Main Page

01

Gowling WLG (Canada) LLP

ERENUMAB

ChemOutsourcing

Not Confirmed

Gowling WLG (Canada) LLP

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-18

Date Granted : 2017-10-03

Brand Name : AIMOVIG

Patent Number : 2746858

Filing Date : 2009-12-18

Strength per Unit : 70 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2029-12-18

Date Granted : 2017-10-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG (Canada) LLP

ERENUMAB

ChemOutsourcing

Not Confirmed

Gowling WLG (Canada) LLP

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-08-10

Date Granted : 2019-09-24

Brand Name : AIMOVIG

Patent Number : 2984254

Filing Date : 2015-08-10

Strength per Unit : 70 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2035-08-10

Date Granted : 2019-09-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gowling WLG (Canada) LLP

ERENUMAB

ChemOutsourcing

Not Confirmed

Gowling WLG (Canada) LLP

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-18

Date Granted : 2017-10-13

Brand Name : AIMOVIG

Patent Number : 2746858

Filing Date : 2009-12-18

Strength per Unit : 70 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2029-12-18

Date Granted : 2017-10-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG (Canada) LLP

ERENUMAB

ChemOutsourcing

Not Confirmed

Gowling WLG (Canada) LLP

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-08-10

Date Granted : 2019-09-24

Brand Name : AIMOVIG

Patent Number : 2984254

Filing Date : 2015-08-10

Strength per Unit : 70 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2035-08-10

Date Granted : 2019-09-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Gowling WLG (Canada) LLP

ERENUMAB

ChemOutsourcing

Not Confirmed

Gowling WLG (Canada) LLP

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-18

Date Granted : 2017-10-03

Brand Name : AIMOVIG

Patent Number : 2746858

Filing Date : 2009-12-18

Strength per Unit : 140 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2029-12-18

Date Granted : 2017-10-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Gowling WLG (Canada) LLP

ERENUMAB

ChemOutsourcing

Not Confirmed

Gowling WLG (Canada) LLP

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-08-10

Date Granted : 2019-09-24

Brand Name : AIMOVIG

Patent Number : 2984254

Filing Date : 2015-08-10

Strength per Unit : 140 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2035-08-10

Date Granted : 2019-09-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Gowling WLG (Canada) LLP

ERENUMAB

ChemOutsourcing

Not Confirmed

Gowling WLG (Canada) LLP

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-18

Date Granted : 2017-10-03

Brand Name : AIMOVIG

Patent Number : 2746858

Filing Date : 2009-12-18

Strength per Unit : 140 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2029-12-18

Date Granted : 2017-10-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Gowling WLG (Canada) LLP

ERENUMAB

ChemOutsourcing

Not Confirmed

Gowling WLG (Canada) LLP

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-08-10

Date Granted : 2019-09-24

Brand Name : AIMOVIG

Patent Number : 2984254

Filing Date : 2015-08-10

Strength per Unit : 140 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2035-08-10

Date Granted : 2019-09-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!